Location History:
- Neshanic Station, NJ (US) (2001 - 2005)
- Hillsborough, NJ (US) (2013)
Company Filing History:
Years Active: 2001-2013
Title: The Innovations of Robert Frank Wagner
Introduction
Robert Frank Wagner is a notable inventor based in Neshanic Station, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work primarily focuses on the development of innovative drug formulations that enhance therapeutic efficacy.
Latest Patents
One of Wagner's latest patents is titled "Galenical formulations of organic compounds." This invention relates to a pharmaceutical oral fixed dose combination comprising solid dosage forms of valsartan, amlodipine, and hydrochlorothiazide. The method of making these formulations includes the creation of monolayer, bilayer, and trilayer solid dosage forms, which are designed to improve patient compliance and treatment outcomes.
Career Highlights
Throughout his career, Robert Frank Wagner has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug formulation.
Collaborations
Wagner has collaborated with esteemed colleagues such as Yoshimitsu Katakuse and Takashi Taike. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Robert Frank Wagner's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His work continues to impact the industry positively, showcasing the importance of innovation in medicine.